$MEIP
MEI Pharma, Inc. Stock $meip

$meip Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000119312520135561 Filed on May 07, 2020

Income Statement

Concept	2020 Q2	2020 Q1	2019 Q1
Revenue	$25.50M	$1.244M	$1.249M
YoY Change	2158.99%	-0.4%	188.45%
Cost Of Revenue	$480.0K	$860.0K	$1.163M
YoY Change	-56.36%	-26.05%	25.05%
Gross Profit	$25.02M	$384.0K	$86.00K
YoY Change	83300.0%	346.51%	-117.3%
Gross Profit Margin	98.1%	30.87%	6.89%
Selling, General & Admin	$4.530M	$3.860M	$3.630M
YoY Change	21.12%	6.34%	45.78%
% of Gross Profit	18.11%	1005.21%	4220.93%
Research & Development	$7.860M	$8.963M	$9.071M
YoY Change	-2.12%	-1.19%	195.38%
% of Gross Profit	31.41%	2334.11%	10547.67%
Depreciation & Amortization	$20.00K	$30.00K	$20.00K
YoY Change	-33.33%	50.0%	100.0%
% of Gross Profit	0.08%	7.81%	23.26%
Operating Expenses	$12.39M	$8.963M	$9.071M
YoY Change	5.18%	-1.19%	195.38%
Operating Profit	$12.63M	-$12.44M	-$12.62M
YoY Change	-207.49%	-1.37%	108.39%
Interest Expense	-$31.11M	$8.110M	-$4.740M
YoY Change	-310.2%	-271.1%	-4409.09%
% of Operating Profit	-246.32%
Other Income/Expense, Net	$0.00	$0.00	-$5.200M
YoY Change	-100.0%	-100.0%
Pretax Income	-$18.48M	-$4.330M	-$17.36M
YoY Change	-705.9%	-75.06%	191.76%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$18.48M	-$4.329M	-$17.35M
YoY Change	-705.37%	-75.05%	191.76%
Net Earnings / Revenue	-72.44%	-347.99%	-1389.43%
Basic Earnings Per Share	-$0.17	-$0.04	-$0.24
Diluted Earnings Per Share	-$0.17	-$0.04	-$0.24
COMMON SHARES
Basic Shares Outstanding	106.0M	106.0M	71.20M
Diluted Shares Outstanding		106.0M	71.20M

Balance Sheet

Concept	2020 Q2	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$182.6M	$92.80M	$82.30M
YoY Change	145.1%	12.76%	127.35%
Cash & Equivalents	$12.33M	$7.438M	$7.426M
Short-Term Investments	$170.3M	$85.40M	$74.90M
Other Short-Term Assets	$5.000M	$2.100M	$3.200M
YoY Change	108.33%	-34.38%	255.56%
Inventory
Prepaid Expenses
Receivables	$600.0K	$500.0K
Other Receivables	$20.40M	$0.00
Total Short-Term Assets	$208.6M	$95.40M	$85.44M
YoY Change	153.83%	11.66%	130.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.084M	$986.0K	$213.0K
YoY Change	431.37%	362.91%	491.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.084M	$1.221M	$483.0K
YoY Change	133.12%	152.8%	41.64%
TOTAL ASSETS
Total Short-Term Assets	$208.6M	$95.40M	$85.44M
Total Long-Term Assets	$1.084M	$1.221M	$483.0K
Total Assets	$209.7M	$96.62M	$85.93M
YoY Change	153.71%	12.45%	129.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.437M	$2.492M	$1.969M
YoY Change	-49.09%	26.56%	56.39%
Accrued Expenses	$6.090M	$5.287M	$5.685M
YoY Change	33.58%	-7.0%	138.66%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$23.30M	$10.26M	$11.85M
YoY Change	62.95%	-13.45%	164.3%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$108.2M	$11.90M	$36.20M
YoY Change	430.39%	-67.13%
Total Long-Term Liabilities	$108.2M	$11.90M	$36.20M
YoY Change	430.39%	-67.13%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.30M	$10.26M	$11.85M
Total Long-Term Liabilities	$108.2M	$11.90M	$36.20M
Total Liabilities	$131.5M	$22.13M	$48.04M
YoY Change	278.63%	-53.95%	967.64%
SHAREHOLDERS EQUITY
Retained Earnings	-$277.2M	-$258.8M	-$234.3M
YoY Change	19.9%	10.45%	20.05%
Common Stock	$355.5M	$333.3M	$272.2M
YoY Change	27.33%	22.45%	19.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$77.06M	$74.50M	$37.88M
YoY Change
Total Liabilities & Shareholders Equity	$209.7M	$96.62M	$85.93M
YoY Change	153.71%	12.45%	129.77%

Cashflow Statement

Concept	2020 Q2	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	-$18.48M	-$4.329M	-$17.35M
YoY Change	-705.37%	-75.05%	191.76%
Depreciation, Depletion And Amortization	$20.00K	$30.00K	$20.00K
YoY Change	-33.33%	50.0%	100.0%
Cash From Operating Activities	$69.11M	-$10.29M	-$11.34M
YoY Change	-957.44%	-9.26%	81.73%
INVESTING ACTIVITIES
Capital Expenditures	-$100.0K	-$780.0K	-$40.00K
YoY Change	900.0%	1850.0%
Acquisitions
YoY Change
Other Investing Activities	-$84.94M	$9.880M	$9.800M
YoY Change	-951.96%	0.82%	92.53%
Cash From Investing Activities	-$85.04M	$9.100M	$9.760M
YoY Change	-953.82%	-6.76%	91.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	20.83M	-10.00K	250.0K
YoY Change	7339.29%	-104.0%
NET CHANGE
Cash From Operating Activities	69.11M	-10.29M	-11.34M
Cash From Investing Activities	-85.04M	9.100M	9.760M
Cash From Financing Activities	20.83M	-10.00K	250.0K
Net Change In Cash	4.900M	-1.200M	-1.330M
YoY Change	124.77%	-9.77%	15.65%
FREE CASH FLOW
Cash From Operating Activities	$69.11M	-$10.29M	-$11.34M
Capital Expenditures	-$100.0K	-$780.0K	-$40.00K
Free Cash Flow	$69.21M	-$9.510M	-$11.30M
YoY Change	-959.75%	-15.84%	81.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	235000
CY2019Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	261000
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	986000
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	204000
CY2020Q1	us-gaap	Assets Assets	96623000
CY2019Q2	us-gaap	Assets Assets	82663000
CY2020Q1	us-gaap	Short Term Investments ShortTermInvestments	85360000
CY2019Q2	us-gaap	Short Term Investments ShortTermInvestments	64899000
CY2020Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	92798000
CY2019Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	74489000
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2604000
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2435000
CY2020Q1	us-gaap	Assets Current AssetsCurrent	95402000
CY2019Q2	us-gaap	Assets Current AssetsCurrent	82198000
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2492000
CY2019Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	4787000
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5287000
CY2019Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4559000
CY2020Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2478000
CY2019Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4955000
CY2020Q1	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	9051000
CY2019Q2	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	17613000
CY2020Q1	us-gaap	Liabilities Liabilities	22125000
CY2019Q2	us-gaap	Liabilities Liabilities	34733000
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	96623000
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	82663000
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	10257000
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	14301000
CY2020Q1	us-gaap	Preferred Stock Value PreferredStockValue
CY2019Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2020Q1	us-gaap	Common Stock Value CommonStockValue
CY2019Q2	us-gaap	Common Stock Value CommonStockValue
CY2020Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	333256000
CY2019Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	279148000
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-258758000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1000
	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	13274000
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-231218000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	74498000
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	47930000
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	860000
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1163000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2189000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3161000
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8963000
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9071000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26206000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24268000
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3864000
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3631000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12189000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10853000
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	13687000
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	13865000
	us-gaap	Costs And Expenses CostsAndExpenses	40584000
	us-gaap	Costs And Expenses CostsAndExpenses	38282000
CY2020Q1	us-gaap	Revenues Revenues	1244000
CY2019Q1	us-gaap	Revenues Revenues	1249000
	us-gaap	Revenues Revenues	3409000
	us-gaap	Revenues Revenues	3785000
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12443000
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12616000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-37175000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-34497000
CY2020Q1	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	7732000
CY2019Q1	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-5201000
	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	8562000
	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	13274000
CY2020Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	382000
CY2019Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	462000
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	1074000
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	1352000
	us-gaap	Net Income Loss NetIncomeLoss	-27540000
	us-gaap	Net Income Loss NetIncomeLoss	-19872000
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105999000
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71200000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85995000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71069000
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105999000
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71200000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	85995000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	72011000
	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	8562000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	54326000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21246000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	14363000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	90000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	52000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	169000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1567000
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-2295000
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1674000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	667000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2231000
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2479000
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	7631000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	785000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	207000
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	90324000
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	39756000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	72000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	319000
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1118000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	324000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	53948000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1113000
CY2020Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2817000
CY2019Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2819000
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-2994000
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-20217000
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	50459000
	us-gaap	Profit Loss ProfitLoss	-27540000
	us-gaap	Profit Loss ProfitLoss	-19872000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-34854000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21359000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	69863000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2152000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5883000
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9590000
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13309000
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7438000
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7426000
	meip	Percentage Of Purchases From Major Suppliers PercentageOfPurchasesFromMajorSuppliers	1.00
	meip	Agreement Termination Notice Period AgreementTerminationNoticePeriod	P90D
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4329000
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17355000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-27540000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19872000
CY2019Q1	meip	Dilutive Securities Effect On Basic Earnings Per Share Change In Fair Value Of Warrant Liability DilutiveSecuritiesEffectOnBasicEarningsPerShareChangeInFairValueOfWarrantLiability	0
	meip	Dilutive Securities Effect On Basic Earnings Per Share Change In Fair Value Of Warrant Liability DilutiveSecuritiesEffectOnBasicEarningsPerShareChangeInFairValueOfWarrantLiability	-23437000
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4329000
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-17355000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-27540000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-43309000
CY2020Q1	meip	Milestone Payments Maximum Amount MilestonePaymentsMaximumAmount	74500000
CY2020Q1	meip	Shelf Registration Statement Value ShelfRegistrationStatementValue	92500000
	meip	Exercise Of Warrants For Common Stock ExerciseOfWarrantsForCommonStock	440043
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1550000
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1514000
	us-gaap	Share Based Compensation ShareBasedCompensation	5434000
	us-gaap	Share Based Compensation ShareBasedCompensation	5114000
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8356961
CY2019Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	159000
CY2019Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	72000
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2113000
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	47280000
CY2019Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	48451000
CY2019Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1771000
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.20
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3503333
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.45
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	46667
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.54
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	72519
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.04
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	557890
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	6.89
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11183218
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.80
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	357242
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5004178
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.59
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y1M6D
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	337674
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.018
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.028
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.736
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.849
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.60
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.95
CY2020Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	5700000
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y7M6D
CY2019Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	5274000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	77285000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-4329000
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-8000
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1550000
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-14542000
CY2018Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-324000
CY2018Q3	meip	Stockissuedduringperiodvaluestockwarrantsexercised Stockissuedduringperiodvaluestockwarrantsexercised	2186000
CY2018Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	43000
CY2018Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1937000
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	39759000
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	12025000
CY2018Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	24000
CY2018Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1663000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	48602000
	meip	Proceeds From Previously Issued Common Stock ProceedsFromPreviouslyIssuedCommonStock	5274000
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	73545
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100
CY2020Q1	meip	Cash And Cash Equivalentsshort Term Investments And Common Stock Proceeds Receivable CashAndCashEquivalentsshortTermInvestmentsAndCommonStockProceedsReceivable	92800000
CY2020Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	5300000
CY2020Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1000
CY2019Q1	meip	Change In Fair Value Of Warrants Exercised ChangeInFairValueOfWarrantsExercised	1068000
CY2019Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	105999
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	2500000
	meip	Additional Recognition Of Deferred Revenue AdditionalRecognitionOfDeferredRevenue	2800000
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	74000
CY2020Q1	meip	Accounts Receivable Net Ending Balance AccountsReceivableNetEndingBalance	74000
CY2019Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	686000
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-174000
CY2020Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	512000
CY2019Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	7774000
CY2020Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5295000
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	27126
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	24207
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	27036
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18818
CY2020Q1	meip	Available Value Of Number Of Shares Agreed To Be Sold Under Agreement AvailableValueOfNumberOfSharesAgreedToBeSoldUnderAgreement	24300000
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Trading Symbol TradingSymbol	MEIP
	dei	Entity Registrant Name EntityRegistrantName	MEI Pharma, Inc.
	dei	Entity Central Index Key EntityCentralIndexKey	0001262104
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	105998677
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2019Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00000002
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00000002
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	226000
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	226000
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	105999
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	73545
CY2019Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	53471000
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-17355000
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	252000
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1514000
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	37882000
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and disclosures made in the accompanying notes to the financial statements. We use estimates that affect the reported amounts (including assets, liabilities, revenues and expenses) and related disclosures. Actual results could materially differ from those estimates. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2019Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
	meip	Number Of Clinical Stage Candidates NumberOfClinicalStageCandidates	4
	meip	Number Of Candidate In An Ongoing Global Registration Trial NumberOfCandidateInAnOngoingGlobalRegistrationTrial	1
	meip	Contract With Customer Asset And Liability ContractWithCustomerAssetAndLiability	<div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents changes in contract assets and contract liabilities during the nine months ended March 31, 2020 (in thousands): </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: "times new roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="padding: 0px;;width:64%;"></td><td style="padding: 0px;;vertical-align:bottom;;width:7%;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;;vertical-align:bottom;;width:7%;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;;vertical-align:bottom;;width:6%;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.5pt; font-family: "times new roman";;vertical-align:bottom;"> </td><td style="padding-bottom: 0.5pt; font-family: "times new roman";;vertical-align:bottom;">  </td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As of June 30,<br/>2019</div></td><td style="padding-bottom: 0.5pt; font-family: "times new roman";;vertical-align:bottom;"> </td><td style="padding-bottom: 0.5pt; font-family: "times new roman";;vertical-align:bottom;">  </td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Net Change</div></td><td style="padding-bottom: 0.5pt; font-family: "times new roman";;vertical-align:bottom;"> </td><td style="padding-bottom: 0.5pt; font-family: "times new roman";;vertical-align:bottom;">  </td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As of March 31,<br/>2020</div></td><td style="padding-bottom: 0.5pt; font-family: "times new roman";;vertical-align:bottom;"> </td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-size: 10pt; background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Receivables</div></div></td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">—  </td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">74</td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">74</td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-size: 10pt;;vertical-align:top;"><div style="text-indent: -1em; font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Contract Assets</div></div></td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="vertical-align:bottom;">$</td><td style="text-align:right;;vertical-align:bottom;">686</td><td style="white-space: nowrap; font-family: "times new roman";;vertical-align:bottom;"> </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="vertical-align:bottom;">$</td><td style="text-align:right;;vertical-align:bottom;">(174</td><td style="white-space: nowrap;;vertical-align:bottom;">) </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="vertical-align:bottom;">$</td><td style="text-align:right;;vertical-align:bottom;">512</td><td style="white-space: nowrap; font-family: "times new roman";;vertical-align:bottom;"> </td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-size: 10pt; background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Contract Liabilities</div></div></td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">7,774</td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2,479</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">) </td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">5,295</td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: "times new roman"; padding: 0px;;vertical-align:top;"></td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td></tr></table><div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	meip	Schedule Of Revenue Associated With License Agreement ScheduleOfRevenueAssociatedWithLicenseAgreement	<div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We recognized revenue associated with the following license agreements (in thousands): </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: "times new roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:92%;"><tr style="font-size: 0px;"><td style="padding: 0px;;width:72%;"></td><td style="padding: 0px;;vertical-align:bottom;;width:3%;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;;vertical-align:bottom;;width:3%;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;;vertical-align:bottom;;width:3%;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;;vertical-align:bottom;;width:3%;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td><td style="padding: 0px;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.5pt;;vertical-align:bottom;"> </td><td style="padding-bottom: 0.5pt;;vertical-align:bottom;">  </td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Three Months Ended<br/>March 31, </div></td><td style="padding-bottom: 0.5pt;;vertical-align:bottom;"> </td><td style="padding-bottom: 0.5pt;;vertical-align:bottom;">  </td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Nine Months Ended<br/>March 31,</div></td><td style="padding-bottom: 0.5pt;;vertical-align:bottom;"> </td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.5pt; font-family: "times new roman";;vertical-align:bottom;"> </td><td style="padding-bottom: 0.5pt; font-family: "times new roman";;vertical-align:bottom;">  </td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 0.5pt; font-family: "times new roman";;vertical-align:bottom;"> </td><td style="padding-bottom: 0.5pt; font-family: "times new roman";;vertical-align:bottom;">  </td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 0.5pt; font-family: "times new roman";;vertical-align:bottom;"> </td><td style="padding-bottom: 0.5pt; font-family: "times new roman";;vertical-align:bottom;">  </td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 0.5pt; font-family: "times new roman";;vertical-align:bottom;"> </td><td style="padding-bottom: 0.5pt; font-family: "times new roman";;vertical-align:bottom;">  </td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 0.5pt; font-family: "times new roman";;vertical-align:bottom;"> </td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-size: 10pt; background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">KKC Japan License Agreement</div></div></td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">812</td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">631</td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,282</td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,992</td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-size: 10pt;;vertical-align:top;"><div style="text-indent: -1em; font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Helsinn License Agreement</div></div></td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="font-family: "times new roman";;vertical-align:bottom;"> </td><td style="text-align:right;;vertical-align:bottom;">432</td><td style="white-space: nowrap; font-family: "times new roman";;vertical-align:bottom;"> </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="font-family: "times new roman";;vertical-align:bottom;"> </td><td style="text-align:right;;vertical-align:bottom;">618</td><td style="white-space: nowrap; font-family: "times new roman";;vertical-align:bottom;"> </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="font-family: "times new roman";;vertical-align:bottom;"> </td><td style="text-align:right;;vertical-align:bottom;">1,127</td><td style="white-space: nowrap; font-family: "times new roman";;vertical-align:bottom;"> </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="font-family: "times new roman";;vertical-align:bottom;"> </td><td style="text-align:right;;vertical-align:bottom;">1,793</td><td style="white-space: nowrap; font-family: "times new roman";;vertical-align:bottom;"> </td></tr><tr style="font-size: 1px;"><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="font-family: "times new roman";"> </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="font-family: "times new roman";"> </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="font-family: "times new roman";"> </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="font-family: "times new roman";"> </td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: "times new roman"; padding: 0px; background-color: rgb(204, 238, 255);;vertical-align:top;"></td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,244</td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,249</td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,409</td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,785</td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td></tr><tr style="font-size: 1px;"><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="font-family: "times new roman";"> </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="font-family: "times new roman";"> </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="font-family: "times new roman";"> </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="font-family: "times new roman";"> </td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-size: 10pt;;vertical-align:top;"><div style="text-indent: -1em; font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Timing of Revenue Recognition:</div></div></div></td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-size: 10pt; background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">License transferred at a point in time</div></div></td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">—  </td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">—  </td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">—  </td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">879</td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-size: 10pt;;vertical-align:top;"><div style="text-indent: -1em; font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Services performed over time</div></div></td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="font-family: "times new roman";;vertical-align:bottom;"> </td><td style="text-align:right;;vertical-align:bottom;">1,244</td><td style="white-space: nowrap; font-family: "times new roman";;vertical-align:bottom;"> </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="font-family: "times new roman";;vertical-align:bottom;"> </td><td style="text-align:right;;vertical-align:bottom;">1,249</td><td style="white-space: nowrap; font-family: "times new roman";;vertical-align:bottom;"> </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="font-family: "times new roman";;vertical-align:bottom;"> </td><td style="text-align:right;;vertical-align:bottom;">3,409</td><td style="white-space: nowrap; font-family: "times new roman";;vertical-align:bottom;"> </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="font-family: "times new roman";;vertical-align:bottom;"> </td><td style="text-align:right;;vertical-align:bottom;">2,906</td><td style="white-space: nowrap; font-family: "times new roman";;vertical-align:bottom;"> </td></tr><tr style="font-size: 1px;"><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="font-family: "times new roman";"> </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="font-family: "times new roman";"> </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="font-family: "times new roman";"> </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="font-family: "times new roman";"> </td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: "times new roman"; padding: 0px; background-color: rgb(204, 238, 255);;vertical-align:top;"></td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,244</td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,249</td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,409</td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td><td style="font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,785</td><td style="white-space: nowrap; font-family: "times new roman"; background-color: rgb(204, 238, 255);;vertical-align:bottom;"> </td></tr><tr style="font-size: 1px;"><td style="font-family: "times new roman"; padding: 0px;;vertical-align:bottom;"></td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="font-family: "times new roman";"> </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="font-family: "times new roman";"> </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="font-family: "times new roman";"> </td><td style="font-family: "times new roman";;vertical-align:bottom;">  </td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="font-family: "times new roman";"> </td></tr></table><div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2020Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	0
CY2019Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	0
	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	0
	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	0
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	meip	Profits And Costs Sharing Ratio ProfitsAndCostsSharingRatio	0.5

Files In Submission

Name	View Source	Status
0001193125-20-135561-index-headers.html	Edgar Link	pending
0001193125-20-135561-index.html	Edgar Link	pending
0001193125-20-135561.txt	Edgar Link	pending
0001193125-20-135561-xbrl.zip	Edgar Link	pending
d888492d10q.htm	Edgar Link	pending
d888492dex311.htm	Edgar Link	pending
d888492dex312.htm	Edgar Link	pending
d888492dex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
g888492g0421103741516.jpg	Edgar Link	pending
meip-20200331.xml	Edgar Link	completed
meip-20200331.xsd	Edgar Link	pending
meip-20200331_cal.xml	Edgar Link	unprocessable
meip-20200331_def.xml	Edgar Link	unprocessable
meip-20200331_lab.xml	Edgar Link	unprocessable
meip-20200331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MEIP
MEI Pharma, Inc. Stock $meip

2020 Q2 Form 10-Q Financial Statement

#000119312520135561 Filed on May 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MEIP MEI Pharma, Inc. Stock $meip

2020 Q2 Form 10-Q Financial Statement

#000119312520135561 Filed on May 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MEIP
MEI Pharma, Inc. Stock $meip